Clinic and Women’s Characteristics and Outcome Assessment during Baseline Period.

aVariables used for randomization, using Phase 1 clinic statistics.
bMean (Standard Deviation).
cN° of women in the Intervention Group: 113; N° of women in the Control Group: 99.
dMedian (Interquartile Range) is reported.
eN° of women in the Intervention Group: 104; N° of women in the Control Group: 90.
fFor those ≥24 weeks; does not include cases with molar or ectopic pregnancies or abortion. N° of women in the Intervention Group: 92; N° of women in the Control Group: 69.
gMAP was measured as ([(2 * diastolic BP)+systolic BP]/3); includes women with non-palpable BP.
hIncludes acute renal failure, acute respiratory distress syndrome, heart failure, cerebral impairment (seizures, unconsciousness, motor/cognitive loss) among women who survived.